ADMC

FTC Approves HISA's Anti-Doping And Medication Rule

Edited Press Release New and enhanced anti-doping regulations took effect in U.S. Thoroughbred horse racing Monday following the Federal Trade Commission's approval of the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program. HISA's ADMC Program, administered by the Horseracing Integrity & Welfare Unit (HIWU), brings all testing and results management under one national authority, standardizes the categories of substances laboratories test for and institutes clear and consistent penalties for violations. In its authority as the independent administrator of the ADMC Program, HIWU is introducing to the...

[ Read More ]
HIWU Set to Administer HISA Anti-Doping and Medication Control Program

Edited Press Release The Horseracing Integrity & Welfare Unit (HIWU), the independent enforcement agency of the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program, has reached arrangements with all state racing commissions and/or racetracks that will be conducting live racing on or soon after the implementation of the ADMC Program, which is anticipated to be Monday, Mar. 27, 2023. The laboratories that will be conducting testing under the Program have also been confirmed. "HIWU appreciates the opportunity to engage with state racing commissions, racetracks, and laboratories...

[ Read More ]
HISA Issues Updated Withdrawal Guidance For Phenylbutazone

The Anti-Doping and Medication Control (ADMC) program has proposed enforcing the screening limit of phenylbutazone at 300 ng/mL in blood, rather than the previously established screening limit of 200 ng/mL in blood. HISA will file Guidance with the Federal Trade Commission that will implement this change in the enforcement of the screening limit. The RMTC's Scientific Advisory Committee (SAC) has been asked by industry stakeholders to review its withdrawal guidance of phenylbutazone based upon the updated proposed screening limit. Based on the updated screening limit of 300 ng/mL in blood...

[ Read More ]
HISA's Anti-Doping And Medication Control Panel Members Revealed

Edited Press Release The individuals who will comprise the Internal Adjudication Panel (IAP), which will hear Controlled Medication Rule Violation Cases under HISA's Anti-Doping and Medication Control (ADMC) Program, were announced Friday by HISA and HIWU. IAP members, who will serve for 4-year terms as independent contractors to both HISA and HIWU, were selected for their deep equine regulatory experience. State stewards will be prohibited from participating in cases originating in their state of employment. All members of the panel will receive training on HISA's adjudication processes under the ADMC...

[ Read More ]
Horseracing Integrity And Welfare Q&A: Denali Stud's Craig Bandoroff

The Horseracing Integrity & Welfare Unit (HIWU) provided this Q&A with questions submitted by Craig Bandoroff of Denali Stud. Although I've read explanations and have had people try to explain it to me I still don't understand why we test to such a small level.  As I understand it a picogram is one-trillionth of a gram.  How can that have any affect on a 1200-lb horse?  Why do we test to such a small level?  Are we using the ARCI recommended guidelines? It is important to remember that a picogram...

[ Read More ]
RMTC Completes Analysis Of HISA Withdrawal Guidance

The Racing Medication and Testing Consortium's Scientific Advisory Committee has now completed its analysis of HISA's proposed ADMC screening limits and detection times and has developed a withdrawal guidance limited to RMTC's schedule of Controlled Therapeutic Substances. This withdrawal guidance is based on existing research and administration data. The complete withdrawal guidance, which is subject to change, can be found here. The intention is for the RMTC to provide the industry with scientifically derived information to aid attending veterinarians and horsemen in making medication decisions and to avoid preventable errors,...

[ Read More ]
HISA Issues Notice On Use Of Bisphosphonates

Edited Press Release In advance of the anticipated effective date of HISA's Anti-Doping and Medication Control (ADMC) Program March 27, the Horseracing Integrity & Welfare Unit (HIWU) calls the Thoroughbred industry's attention to regulations regarding the presence and use of bisphosphonates in covered horses. Bisphosphonates are a class of medication prescribed for managing clinical signs associated with navicular syndrome in horses 4-years-old or above. They also have a history of extra-label use in younger horses. Bisphosphonates may be detected in samples from treated horses for months to years after administration....

[ Read More ]
HISA Q&A: The ADMC Program

Edited Press Release With the anticipated March 27 implementation of the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program approaching, it's increasingly important for all racing participants to understand how the Program will work. The following are HISA's answers to five frequently asked questions about the ADMC Program. How will the new HISA ADMC Program impact the lives and workflow of horsemen? The ADMC Program is designed to create centralized testing and results management processes and apply uniform penalties for violations efficiently and consistently across the...

[ Read More ]
California First to Sign Voluntary Agreement, Pay HISA 2023 Fees

The Golden State is the first jurisdiction in the country to sign a voluntary agreement with the Horseracing Integrity & Welfare Unit (HIWU) to continue performing a host of vital roles when the Horseracing Integrity and Safety Act's (HISA) drug control program goes into effect Mar. 27, according to a statement Friday by the California Horse Racing Board (CHRB). In another first among the nation's racing jurisdictions, the CHRB also agrees to pay HISA's 2023 fee assessment. The total figure for the state is more than $6.7 million. However, after...

[ Read More ]
At 1-Month Mark For Drug Control, HISA Braces Industry For Changes

Four weeks out from the anticipated effective date for the Anti-Doping and Medication Control Program (ADMC), the Authority overseeing the Horseracing Integrity and Safety Act (HISA) is stepping up its awareness campaign so industry participants can be properly prepared for a sweeping change in regulatory protocols. "We are officially on the one-month countdown to what we are confident will be the launch of our ADMC program on Mar. 27," Lisa Lazarus, the chief executive officer for the HISA Authority, said during a Monday video press conference. "Everyone is sort of...

[ Read More ]
HIWU Appoints Three to Executive Team

The Horseracing Integrity & Welfare Unit (HIWU) announced three appointments to its executive leadership team-Ben Mosier to the role of Executive Director, Kate Mittelstadt to Chief of Operations, and Michelle Pujals to General Counsel. Both Mittelstadt and Pujals will report to Mosier. The Horseracing Integrity and Safety Authority (HISA), in consultation with HIWU, is preparing to submit draft regulations for the Anti-Doping and Medication Control (ADMC) Program to the U.S. Federal Trade Commission for review ahead of implementation of the Program Jan. 1, 2023. Mosier joined Drug Free Sport International...

[ Read More ]
Lazarus on HISA Anti-Doping and Medication Control

Bit by bit, the pieces of the puzzle are slotting into place for the Anti-Doping and Medication Control (ADMC) component of the Horseracing Integrity and Safety Act, set to go into effect at the start of next year. Last month, that program was designated an agency to officially run it--namely Drug Free Sports International, an organization that has helped administer drug testing programs to a slew of major human sports leagues. Then, last week, the draft ADMC rules were for put out public comment. These draft rules can be found...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.